Harmony Biosciences Holdings, Inc. (HRMY)

HRMY Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 14, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,076	1,962	1,892	3,268	2,493	2,057
Market Cap Growth	6.42%	3.73%	-42.12%	31.09%	21.23%	-
Enterprise Value	1,573	1,737	1,721	3,155	2,496	2,028
Last Close Price	36.04	34.41	32.30	55.10	42.64	36.15
PE Ratio	11.38	13.49	14.68	18.01	72.07	-
Forward PE	9.65	11.82	11.14	23.01	25.27	35.10
PS Ratio	2.51	2.75	3.25	7.47	8.16	12.87
PB Ratio	2.49	2.98	4.05	8.11	13.37	21.16
P/TBV Ratio	2.81	3.60	5.74	13.51	58.54	-
P/FCF Ratio	6.99	8.98	8.64	22.65	25.37	-
P/OCF Ratio	6.97	8.93	8.62	22.62	25.30	-
PEG Ratio	0.38	0.47	0.73	-	-	-
EV/Sales Ratio	1.90	2.43	2.96	7.21	8.17	12.69
EV/EBITDA Ratio	6.30	8.08	7.95	21.98	23.46	74.48
EV/EBIT Ratio	6.97	9.10	8.96	26.25	28.51	119.37
EV/FCF Ratio	5.30	7.95	7.86	21.87	25.40	-
Debt / Equity Ratio	0.20	0.28	0.42	0.48	1.05	2.00
Debt / EBITDA Ratio	0.68	0.84	0.90	1.34	1.82	7.14
Debt / FCF Ratio	0.57	0.83	0.90	1.35	1.99	-
Asset Turnover	0.77	0.79	0.78	0.79	0.71	0.60
Inventory Turnover	26.70	24.97	25.10	19.13	13.45	11.30
Quick Ratio	3.46	3.14	2.61	4.79	5.01	1.86
Current Ratio	3.76	3.31	2.75	5.07	5.29	1.95
Return on Equity (ROE)	25.93%	25.84%	29.63%	61.58%	24.39%	-86.32%
Return on Assets (ROA)	13.20%	13.17%	16.16%	13.57%	12.71%	3.98%
Return on Capital (ROIC)	15.78%	15.86%	19.05%	15.34%	16.24%	5.62%
Return on Capital Employed (ROCE)	22.90%	23.20%	29.60%	20.20%	23.10%	5.80%
Earnings Yield	8.94%	7.41%	6.81%	5.55%	1.39%	-1.80%
FCF Yield	14.30%	11.14%	11.58%	4.42%	3.94%	-0.14%
Buyback Yield / Dilution	-1.02%	4.15%	1.19%	-3.19%	-129.72%	-231.37%

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q